Skip Navigation LinksHome > March 2012 - Volume 31 - Issue 3 > Incidence of Intussusception Among Infants in a Large Commer...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e31824213b1
Vaccine Reports

Incidence of Intussusception Among Infants in a Large Commercially Insured Population in the United States

Mona Eng, Patricia SCD*; Mast, T. Christopher PhD, MS; Loughlin, Jeanne MS*; Clifford, C. Robin MS*; Wong, Judy BA*; Seeger, John D. PharmD, DrPH*,‡,§

Collapse Box

Abstract

Background: To estimate the incidence of intussusception among infants treated in inpatient and emergency department settings during the period preceding the US launch of second-generation rotavirus vaccines.

Methods: From a large US health insurance claims database, we sampled 100,000 infants aged 1 to 3 months at first diphtheria-tetanus-acellular pertussis vaccination between 2001 and 2005. Potential intussusception cases were identified on the basis of claims and were confirmed by medical record review. Incidence rates (IRs) and 95% confidence intervals (CIs) were estimated based on follow-up from first diphtheria-tetanus-acellular pertussis dose to up to 1 year of age, and within 21, 30, and 60 days after each dose.

Results: The IR of intussusception in the first year of life was 0.33/1000 person-years based on 22 confirmed cases (95% CI: 0.21–0.50/1000 person-years). The age-specific incidence peaked among infants aged 5 months (IR: 0.82/1000 person-years; 95% CI: 0.30–1.78/1000 person-years). During the 21, 30, and 60 days following any dose, the incidence per 1000 person-years was 0.27, 0.24, and 0.33, respectively.

Conclusion: The rates described in this study can serve as a benchmark for comparison with incidences observed after the introduction of the second-generation rotavirus vaccines.

© 2012 by Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.